Manufacturer record
Skymap Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
31 batches manufactured by Skymap Pharmaceuticals Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between February 2020 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SPA252793, Rabeprazole Gastro-Resistant Tablets IP (exp Nov 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Dissolution (Buffer Stage). Listed in the September 2026 alert.
Records by type
31 records linked to Skymap Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Gastro-Resistant Tablets IP | Batch SPA252793Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Dissolution (Buffer Stage)Dissolution | RDTL, ChandigarhCDSCO lab | Sep 2026 |
| Pantoprazole Gastro-resistant Tablets IP | Batch GD25214Mfg Dec 2025 · Exp Nov 2027 | TEST FOR DISSOLUTIONDissolution | DTL, DelhiState lab | Jul 2026 |
| Glipizide Tablets IP | Batch SPA252473Mfg Nov 2025 · Exp Oct 2027 | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab | Jul 2026 |
| Ofloxacin Tablets IP | Batch SPA252289Mfg Oct 2025 · Exp Sep 2028 | Failed Dissolution testDissolution | DTL, PuducherryState lab | Jun 2026 |
| Cefixime Dispersible Tablets IP 200 mg | Batch AB24069Mfg Nov 2024 · Exp Oct 2026 | MisbrandedMisbranded | SDTL, UttarakhandState lab | May 2026 |
| Pepsin & Fungal Diastase Syrup | Batch SPA250909Mfg Apr 2025 · Exp Sep 2026 | The sample does not conform to Manufacturer's Specification with respect to Test for Identification and Assay of Pepsin activityAssay | CDL, KolkataCDSCO lab | Apr 2026 |
| Pantoprazole Gastro-Resistant Tablets IP (Pantoziv 40) | Batch GD24157Mfg Sep 2024 · Exp Aug 2026 | Dissolution in Buffer Stage for PantoprazoleDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Calagy (Calamine Lotion I.P.) | Batch SPA243 098Mfg Oct 2024 · Exp Sep 2026 | Sample does not conforms to clain as per I.P. 2022 w.r.t. assay of Zinc OxideAssay | State labState lab | Mar 2025 |
| Ofloxacin Ornidazole Tablets IP | Batch AD24059Mfg Apr 2024 · Exp Mar 2026 | Note: the sample received does not conformtoi.p.2022 specification with respect to the test for dissolution for the content of ofloxacin and ornidazole (s1, s2 and s3 level) only. Cdtlh report no.: cdtlh/0131/f -Dissolution | CDTL HyderabadCDSCO lab | May 2024 |
| LactuloseSolution U.S.P. | Batch GA2312 7Mfg Nov 2023 · Exp Oct 2025 | The sample does not conforms to claim as per U.S.P.in respect to the Assay.Assay | CDL KolkataCDSCO lab | May 2024 |
| Metoprolol Tablets IP 25 mg | Batch GM23018Mfg Jul 2023 · Exp Jun 2025 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Mar 2024 |
| Diltizem Tablets IP 60mg | Batch GM23005Mfg Mar 2023 · Exp Feb 2025 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Dec 2023 |
| Diltiazem Tablets IP 30 mg | Batch GM22021Mfg Apr 2022 · Exp Mar 2024 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Sep 2023 |
| Metopal ? 50 XL (Metoprolol Succinate Extended Release Tablets IP) | Batch JD22036Mfg Jun 2022 · Exp May 2024 | Dissolution & Assay of Metoprolol SuccinateAssay | CDL KolkataCDSCO lab | Apr 2023 |
| Pioglitazone Hydrochloride Tablets IP 30 mg | Batch GM21077Mfg Aug 2021 · Exp Jul 2023 | DissolutionDissolution | CDTL KolkataCDSCO lab | Mar 2023 |
| Lactuedge (Lactulose Solution USP) | Batch GA22005Mfg Feb 2022 · Exp Jan 2024 | Assay and Organic ImpuritiesAssay | CDTL MumbaiCDSCO lab | Mar 2023 |
| Montelukast Sodium Tablets IP 5 mg | Batch GM21075Mfg Aug 2021 · Exp Jul 2023 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2022 |
| Domperidone Tablets IP 10 mg (Domcolic Tablets) | Batch GSM0040Mfg Oct 2021 · Exp Sep 2023 | IdentificationIdentification | RDTL ChandigarhCDSCO lab | Nov 2022 |
| Sertraline Tablets I.P. 50 mg | Batch GM20105Mfg Nov 2020 · Exp Oct 2022 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2022 |
| Albithral 500 (Azithromycin Tablets IP) | Batch DD21007Mfg Jan 2021 · Exp Dec 2022 | DescriptionDescription | CDTL MumbaiCDSCO lab | Apr 2022 |
| Trimetazidine Modified Release Tablets | Batch GM20134Mfg Nov 2020 · Exp Oct 2022 | DescriptionDescription | CDL KolkataCDSCO lab | Mar 2022 |
| Byzyme (Pepsin & Fungal Diastase Syrup), 200ml | Batch ZA20781Mfg Oct 2020 · Exp Mar 2022 | AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| WARZYME Digestive Enzymes (Pepsin & Fungal Diastase Syrup), 200 ml | Batch AA21036Mfg Jun 2021 · Exp Nov 2022 | Assay of Pepsin & Fungal DiastaseAssay | CDL KolkataCDSCO lab | Jan 2022 |
| Trimetazidine Modified Release Tablets 35 mg | Batch GM21063Mfg Jun 2021 · Exp May 2023 | Average weightWeight | CDTL MumbaiCDSCO lab | Dec 2021 |
| Trimetazidine Modified Release Tablets 35 mg | Batch GM20173Mfg Nov 2020 · Exp Oct 2022 | Average weightWeight | CDTL MumbaiCDSCO lab | Dec 2021 |
| Omeprazole Gastro- Resistant Capsules IP 20 mg | Batch GM20126Mfg Nov 2020 · Exp Oct 2022 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Dec 2021 |
| Omeprazole Gastro-Resistant Capsules IP 20 mg | Batch GM20033Mfg Mar 2020 · Exp Feb 2022 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Jun 2021 |
| Sertraline Tablets IP 50 mg | Batch GM19030Mfg Sep 2019 · Exp Aug 2021 | DissolutionDissolution | CDTL MumbaiCDSCO lab | May 2021 |
| Prolonged-release Diltiazem Tablets BP 90mg | Batch GM20128Mfg Nov 2020 · Exp Oct 2022 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Feb 2021 |
| PREGINATE (Doxylamine Succinate & Pyridoxine Hydrochloride Tablets) | Batch ZD19107Mfg Feb 2019 · Exp Jan 2021 | Description & Assay of Doxylamine SuccinateAssay | CDL KolkataCDSCO lab | Jul 2020 |
| Biodipin 5 (Amlodipine Tablets IP) | Batch ZD19769Mfg Sep 2019 · Exp Aug 2021 | Related SubstancesRelated substances | CDTL MumbaiCDSCO lab | Feb 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.